ET
BLFS icon

Entropy Technologies’s BioLife Solutions BLFS Stock Holding History

Entropy Technologies’s Portfolio BLFS Stock Details BLFS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-11,123
Closed -$181K – 723
2023
Q4 		$181K Buy
+11,123
New +$142K 0.03% 523

Other funds holding BLFS

CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return
CRM
Cramer Rosenthal McGlynn Stamford, Connecticut $1.36B AUM 31.72% 1-Year Est. Return

Entropy Technologies's BLFS Position: Q1 2024 in Review

Entropy Technologies sold out of BioLife Solutions (BLFS) in Q1 2024, closing a stake of 11,123 shares — an estimated $181K sold.

Entropy Technologies first reported a position in BLFS in Q4 2023 and held it in 1 quarter. The position peaked at $181K in Q4 2023. 149 funds tracked by Wall St. Rank hold BLFS as of Q1 2024.

  • Entropy Technologies reported no remaining BioLife Solutions position as of Q1 2024 after selling out during the quarter.
  • Entropy Technologies sold 11,123 BioLife Solutions shares in Q1 2024, an estimated $181K.
  • Entropy Technologies first reported a position in BioLife Solutions in Q4 2023 and held it in 1 quarter.
  • Entropy Technologies's BioLife Solutions position peaked at $181K in Q4 2023.
  • 149 funds tracked by Wall St. Rank held BioLife Solutions as of Q1 2024.

Based on Entropy Technologies's 13F filing for Q1 2024, filed 8 May 2024.